FDA Investigator David K Glasgow
David K Glasgow has inspections in 6 countries as of 04 Aug 2023. David K Glasgow has collaborated with a combined 1962 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
55
Last Inspection Date:
04 Aug 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America,
Croatia,
Czechia,
Sweden,
Spain,
Brazil
Co-Investigator(s):
Adriana N Jimenez Lopez,
Amanda M Osteen,
Amber G Chung,
Ana P Barido,
Andrew R Wasko,
Antoine Nel Hage,
Arindam Dasgupta, PhD,
Ashley M Whitehurst,
Barbara J Holladay,
Brandon L Mariner,
Carla C Tuite,
Carla J Lundi,
Carol Mrivera Lopez, PhD,
Carrie L Doupnik,
Catherine Whiteside, PhD,
Cecil D Mitchell,
Charles A Snipes, PhD,
Charles Kerns,
Charles M Kerns, BLT DO,
Chrissy J Cochran,
Christine M Smith,
Christine M Whitby, CSO,
Christine Mwhitby Smith,
Christine W Twohy,
Courtney N Long,
Ct Viswanathan, PhD,
Cynthia A Harris, MD, RN,
David L Chon,
Dawn C Olenjack,
Debra L Boyd Seale,
Dennis R Downer,
Dr. Abhijit Raha, PhD,
Dr. Zhou Chen (nmi), MD PhD,
Earl Echon,
Edward E Lockwood (EEL),
Edward P Potter,
Emest F Bizjak,
Emily A Green,
Eric M Padgett,
Erickson,
Erin L Mcfiren,
Erin M Mcdowell,
Gerald W Miller,
Hector J Colon Torres,
Hugh M Mcclure, II,
Jacqueline A O'shaughnessy, PhD,
James D Planchon,
James I Giefer,
Jeanne D Shaffer,
Jeffrey A Sommers,
John A Iwen,
John A Kadavil, PhD,
John Dan,
John J Walsh,
John J Welsh, PhD,
John Kadavil, PhD,
Joseph D Gong,
Jyoti B Patel, PhD,
Karen C Daugherty,
Karen M Montgomery (KMM),
Kathleen B Swat,
Kelly D Sheppard,
Kenneth Nieves,
La Tasha M Gunter,
Ladislav Kermet,
Lakisha M Williams,
Linhart,
Lisa Hayka,
Lori S Lawless,
LT Melanie M Mayor, USPHS,
Lynette P Salisbury,
Marya F Ricks,
Meisha R Sampson,
Meisha Waters,
Melissa J Garcia,
Michael F Skelly, PhD,
Miguel A Martinez,
Mra Davism,
Nancy L Meade,
Nicholas L Paulin,
Pamela L Vega,
Philip J Boston,
Regina Gibson Melton,
Rina Bhikha,
Robert D Tollefsen,
Robert J Nesselhauf,
Ruark Lanham,
Sarah Forney,
Shafiq S Ahadi,
Shavon L Square,
Sherry L Secrist, BLT DO,
Shusheen A Alexander,
Simone E Pitts,
Stacey A Priest,
Stephanie L Shapley,
Stephanie Mangigian, MS/OSH, RN,
Steven J Thurber,
Susan J Essenmacher,
Susanna E Ford, Analyst,
Tamika E Allen, RN,
Tania E Vizcaino,
Tanika E Allen, RN,
Tracy L Taras,
William A Warnick,
Young M Yoon
David K Glasgow's Documents
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more